NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

** HEALTH RESEARCH SHOWCASE THURSDAY 29 MAY 2025 **

News

You are here: Home > Cardiovascular Medicine > Heart warning over “fight or flight” tumour

Heart warning over “fight or flight” tumour

16 May 2016 · Listed under Cardiovascular Medicine, Other News

A rare tumour that randomly secretes stress hormones – historically leading some doctors to diagnose sufferers with a psychiatric disorder – does more damage to the heart than previously thought, University of Oxford research reports today.

In the largest study of its kind, researchers said phaeochromocytoma tumours in the adrenal glands, which sit above the kidneys, are likely to suffer inflammation and small areas of scarring of the heart as a result of their condition.

After analysing more than 60 patients at Oxford’s John Radcliffe Hospital using sophisticated cardiac MRI scans, researchers found persistent problems with the heart contracting and relaxing in some patients, even when the heart looks like it is pumping normally.

This goes against previous research which said the heart would return to normal as long as the tumour is removed.

The new research also proposes that it is stress hormones and not the associated high blood pressure as previously thought that have a direct toxic effect on the heart.

The findings were made possible by the use of MRI machines at the University of Oxford Centre for Clinical Magnetic Resonance Research at the JR hospital. It is the first large scale study to use MRI in phaeochromocytoma tumours.

The adrenal glands secrete stress hormones to produce a “fight or flight” response to control heart rate, metabolism and blood pressure so the person can function when stressed.

Phaeochromocytomas can cause the glands to produce too much of these hormones at random times, resulting in heart palpitations, sweating, headaches and high blood pressure when not stressed.

The study scanned 29 people with newly diagnosed phaeochromocytoma before and after surgery, 31 who had had the tumour removed as well as healthy volunteers and people with high blood pressure.

It found those with high blood pressure did not have as much scarring and inflammation of the heart as those with phaeochromocytoma.

The study also reported that patients with pheochromocytoma typically do not have thickened hearts like those with uncontrolled high blood pressure, leading to the conclusion that the hormones, and not high blood pressure, causes this damage.

The study was funded by the NIHR Oxford Biomedical Research Centre and supported by the Alberta Innovates Health Solutions Clinical Fellowship, the University of Oxford Clarendon Fund Scholarship and British Heart Foundation Centre of Research Excellence, Oxford.

← Statin treatment before heart surgery does not prevent heart damage or atrial fibrillation
Immediate aspirin after mini-stroke substantially reduces risk of major stroke →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre